Trials / Completed
CompletedNCT02331706
IFN-DLI for Relapsed Acute Leukemia After Allo-SCT
A Pilot Study to Determine the Feasibility of Conventional Induction Chemotherapy Followed by G-CSF Mobilized Donor Leukocyte Infusion (DLI) and IFN-α (IFN-DLI) for Relapsed Acute Leukemia After Allogeneic Stem Cell Transplantation.
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial is designed to determine the feasibility of conventional induction chemotherapy, IFNand G-CSF mobilized DLI (IFN-DLI) in subjects with relapsed AML and ALL after allo-SCT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Interferon alpha-2B (IFN-α) 3 million units (MU) subcutaneous daily |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-11-11
- Completion
- 2017-11-11
- First posted
- 2015-01-06
- Last updated
- 2020-04-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02331706. Inclusion in this directory is not an endorsement.